Commault Systems, Inc.
CVLT
$88.87
+10.25%
CommVault Systems, Inc. is a provider of data and information management software applications and services, operating within the Software - Application industry. The company is a recognized player in enterprise data backup, recovery, and management, with a distinct identity built on its comprehensive software suite including solutions like HyperScale X and Cleanroom Recovery. The current investor narrative is dominated by a significant stock price decline following its Q3 FY2026 earnings report, which has sparked debate over the company's near-term growth trajectory and competitive positioning in a challenging market environment.…
CVLT
Commault Systems, Inc.
$88.87
Investment Opinion: Should I buy CVLT Today?
Rating: Hold. The core thesis is that CVLT is a fundamentally sound company caught in a severe growth scare, making it a high-risk, high-potential-reward situation that is only suitable for risk-tolerant investors awaiting a turnaround catalyst.
Supporting this view, the stock trades at a seemingly reasonable forward P/E of 16.6x based on expected EPS of $6.28, a significant discount to its trailing multiple of 90.9x. The company maintains a robust gross margin of 81.11%, generates substantial TTM free cash flow of $181.48 million, and has a fortress balance sheet with a debt-to-equity ratio of 0.034. However, these strengths are counterbalanced by the severe -55.67% six-month price decline and the concerning deceleration in quarterly revenue growth.
The thesis would upgrade to a Buy if the company demonstrates a re-acceleration of revenue growth back above 25% YoY in the next quarter, confirming the slowdown was temporary. It would downgrade to a Sell if revenue growth decelerates further below 15% YoY or if the stock breaks decisively below the $74.94 support level on high volume. Relative to its own turbulent history and the growth deceleration, the stock appears fairly valued to slightly undervalued, but the valuation verdict is clouded by extreme uncertainty over future growth rates.
Sign up to view all
CVLT 12-Month Price Forecast
The outlook for CVLT is highly bifurcated and hinges almost entirely on the trajectory of its top-line growth. The base case (50% probability) is a period of volatile consolidation as the company attempts to prove the slowdown is temporary. The bear case risk is substantial, given the stock's proximity to 52-week lows. The stance is neutral due to the high uncertainty; the compelling valuation (forward P/E 16.6x) is offset by deteriorating momentum. The stance would upgrade to bullish on evidence of growth re-acceleration and downgrade to bearish on a breakdown below $74.94 support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Commault Systems, Inc.'s 12-month outlook, with a consensus price target around $115.53 and implied upside of +30.0% versus the current price.
Average Target
$115.53
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$71 - $116
Analyst target range
Analyst coverage appears limited in the provided dataset, with only one analyst's estimates shown for EPS and revenue, suggesting insufficient data to form a robust consensus. The implications of limited coverage can include higher volatility and less efficient price discovery, which may be contributing to the stock's sharp decline. The institutional ratings data shows recent activity, with a notable downgrade from William Blair from 'Outperform' to 'Market Perform' on March 23, 2026, which likely contributed to negative sentiment. Other firms, including DA Davidson, Wells Fargo, and Keybanc, have maintained 'Buy' or 'Overweight' ratings as of late January, following the Q3 earnings report, indicating a divergence of opinion. The wide spread in analyst views, from downgrades to maintained bullish stances, signals high uncertainty regarding the company's near-term path and the appropriate valuation following its disappointing results.
Bulls vs Bears: CVLT Investment Factors
The evidence currently tilts bearish, driven by the severe technical breakdown and the alarming deceleration in revenue growth from over 30% to 19.5% YoY. The bull case rests on a valuation reset (forward P/E of 16.6x), strong cash flow, and a pristine balance sheet, suggesting the sell-off may be overdone. The single most important tension in the investment debate is whether the Q3 growth slowdown is a temporary execution hiccup or the beginning of a sustained trend of market share loss and competitive erosion. The resolution of this growth trajectory question will determine if the current price represents a deep value opportunity or a value trap.
Bullish
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $181.48 million. This provides a solid financial foundation for internal funding of operations and its ongoing share repurchase program, which saw $40.74 million in stock repurchased in the latest quarter.
- Healthy Balance Sheet with Minimal Debt: CVLT maintains a strong financial position with a low debt-to-equity ratio of 0.034 and a current ratio of 1.14. This low leverage provides significant financial flexibility and reduces risk in a challenging market environment.
- Attractive Forward Valuation: The stock's forward P/E of 16.6x, based on analyst EPS estimates of $6.28, is significantly lower than its trailing P/E of 90.9x. This suggests the market is pricing in a substantial earnings recovery, potentially offering value if the company meets expectations.
- High Gross Margin Business Model: The company boasts a robust gross margin of 81.11% (Q3 FY2026), which is strong for a software company. This high-margin profile provides a buffer against operational cost pressures and supports profitability.
Bearish
- Severe Growth Deceleration: Q3 revenue growth decelerated sharply to 19.5% YoY, down from the 30%+ YoY increases seen in Q1 and Q2 of FY2026. This slowdown in top-line expansion is a primary driver of the stock's -55.67% six-month decline and raises concerns about competitive pressures or market saturation.
- Extreme Technical Downtrend: The stock is in a severe downtrend, trading at $79.93, which is near its 52-week low of $74.94 and represents a -51.96% decline over one year. The price is at approximately 40% of its 52-week range, indicating persistent selling pressure and a lack of buyer conviction.
- Volatile and Compressing Profitability: Operating income in Q3 was $19.77 million, down from $25.09 million in Q1, signaling margin compression. This volatility, coupled with a trailing P/E of 90.9x, suggests earnings are not yet stable enough to support a high valuation multiple.
- Limited Analyst Coverage & Downgrade: Analyst coverage appears limited, with only one firm's estimates provided, suggesting higher volatility and less efficient price discovery. The notable downgrade from William Blair from 'Outperform' to 'Market Perform' on March 23, 2026, directly contributed to negative sentiment.
CVLT Technical Analysis
The stock is in a severe and sustained downtrend, with a 1-year price change of -51.96% and a 6-month decline of -55.67%. As of the latest close of $79.93, the price is trading at approximately 40% of its 52-week range ($74.94 to $200.68), positioning it near multi-year lows, which suggests either a deep value opportunity or a fundamental breakdown that the market is pricing in. Recent momentum shows continued weakness, with the stock down -8.13% over the past month and -35.63% over the past three months, indicating the downtrend is persisting without signs of a meaningful reversal. The stock's beta of 0.623 suggests it has been less volatile than the broader market during this period, but its relative strength figures, such as -74.16 over one year, show it has dramatically underperformed the SPY, which was up 22.2%. Key technical levels are clear, with immediate support at the 52-week low of $74.94 and resistance far above near the 52-week high of $200.68; a breakdown below $74.94 could signal further capitulation, while any recovery would need to overcome significant overhead supply.
Beta
0.62
0.62x market volatility
Max Drawdown
-61.5%
Largest decline past year
52-Week Range
$72-$201
Price range past year
Annual Return
-41.3%
Cumulative gain past year
| Period | CVLT Return | S&P 500 |
|---|---|---|
| 1m | +9.9% | +0.5% |
| 3m | -28.4% | -2.1% |
| 6m | -47.8% | +4.0% |
| 1y | -41.3% | +29.5% |
| ytd | -28.4% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CVLT Fundamental Analysis
Revenue growth remains positive but shows signs of deceleration; the most recent quarterly revenue was $313.83 million, representing a 19.5% year-over-year increase. However, this growth rate is down from the 30%+ YoY increases seen in prior quarters of FY2026 (Q1 and Q2), indicating a slowdown in the top-line expansion that is likely concerning investors. The company is profitable, with a net income of $17.78 million in Q3 and a gross margin of 81.11%, which is robust for a software company. Profitability metrics have been volatile, as operating income of $19.77 million in Q3 was down from $25.09 million in Q1, suggesting margin compression, potentially due to increased investment or competitive pressures. The balance sheet is healthy with a low debt-to-equity ratio of 0.034 and a current ratio of 1.14, indicating sufficient short-term liquidity. The company generates solid free cash flow, with TTM FCF of $181.48 million, providing internal funding for operations and its ongoing share repurchase program, as evidenced by the $40.74 million in stock repurchased in the latest quarter.
Quarterly Revenue
$313832000.0B
2025-12
Revenue YoY Growth
+0.19%
YoY Comparison
Gross Margin
+0.81%
Latest Quarter
Free Cash Flow
$181482000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CVLT Overvalued?
Given the positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 90.9x, while the forward P/E is significantly lower at 16.6x. This wide gap implies the market expects a substantial recovery in earnings, aligning with analyst EPS estimates averaging $6.28 for the forward period. Compared to the provided valuation data, the stock's Price/Sales ratio of 6.95 and EV/Sales of 2.97 are more reasonable multiples that investors may focus on given the earnings volatility. Historical context shows the current trailing P/E of 90.9x is near the top of its own historical range observed over the past several quarters, which have fluctuated wildly from negative values to over 150x. This high historical multiple suggests the stock is pricing in optimistic future earnings recovery, but the recent price crash indicates those expectations are being sharply recalibrated, potentially creating a valuation reset.
PE
90.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -2266x~498x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
73.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on earnings volatility and growth sustainability. The sharp deceleration in revenue growth to 19.5% YoY, down from prior quarters above 30%, poses a significant risk to the forward P/E multiple of 16.6x, which is predicated on an earnings recovery. Operating income has also been volatile, declining from $25.09 million in Q1 to $19.77 million in Q3, indicating potential margin pressure from increased competition or investment needs. While the balance sheet is strong, the company's valuation remains highly sensitive to its ability to re-accelerate growth and stabilize profitability.
Market & Competitive Risks are pronounced given the stock's dramatic repricing. Trading near its 52-week low after a -51.96% annual decline, CVLT faces valuation compression risk if growth continues to moderate. Its beta of 0.623 suggests it has been less volatile than the market, but its catastrophic underperformance (-74.16 relative strength) is a clear company-specific issue, likely reflecting concerns about its competitive moat in the data management software space. The recent analyst downgrade highlights growing skepticism about its near-term prospects in a challenging environment.
The Worst-Case Scenario involves a continuation of the growth deceleration into a decline, coupled with further margin compression, leading to missed forward EPS estimates of $6.28. This could trigger additional analyst downgrades and a loss of investor confidence, pushing the stock to re-test and break below its 52-week low of $74.94. Given the stock's history of a -61.53% max drawdown, a realistic adverse scenario could see a further decline of 20-30% from the current $79.93, translating to a loss of approximately -$16 to -$24 per share, landing in the $56-$64 range.
FAQ
The primary risk is sustained growth deceleration, as seen in Q3 where revenue growth slowed to 19.5% from over 30%. Competitive risk is high in the cloud data management space against larger players. Valuation risk is acute, as the forward multiple depends entirely on an earnings recovery that may not materialize. Finally, sentiment risk is severe, evidenced by the stock's -74.16 relative strength underperformance versus the SPY, which could lead to further selling on any negative news.
The 12-month forecast is highly uncertain, with three distinct scenarios. The base case (50% probability) targets a range of $90-$110, assuming growth stabilizes. The bull case (25% probability) targets $140-$165 if growth re-accelerates. The bear case (25% probability) targets $65-$75 if the slowdown worsens. The most likely scenario is the base case, which assumes the company meets lowered growth expectations and the stock recovers modestly from deeply oversold levels. The key assumption is that Q3's 19.5% growth rate represents a new, stable baseline, not the start of a further decline.
The valuation is schizophrenic and depends on the timeframe. Based on trailing earnings, it appears extremely overvalued with a P/E of 90.9x. However, based on forward analyst estimates, it appears reasonably or even undervalued with a forward P/E of 16.6x. The Price/Sales ratio of 6.95 is more grounded. The market is currently pricing in a significant earnings recovery. Therefore, the stock is fairly valued to slightly undervalued only if the company meets its forward EPS target of $6.28; otherwise, it remains overvalued relative to its current growth trajectory.
CVLT presents a high-risk, high-potential-reward opportunity rather than a clear-cut 'good buy.' For risk-tolerant investors, the forward P/E of 16.6x and strong balance sheet (D/E 0.034) may be attractive if the company can arrest its growth deceleration. However, the -51.96% annual decline and severe technical damage indicate significant fundamental concerns. It could be a good buy for a speculative portion of a portfolio for those who believe the growth scare is overblown, but it is not suitable for conservative investors.
CVLT is unsuitable for short-term trading due to its high volatility, negative momentum, and binary dependence on quarterly earnings reports. It is better suited for a long-term (2+ year) investment horizon, allowing time for a potential operational turnaround to unfold. The company's lack of a dividend and its current growth-focused (but slowing) profile further supports a long-term, capital appreciation-oriented strategy. Investors should be prepared for significant volatility and have the patience to wait for the growth narrative to potentially improve.